BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4089767)

  • 21. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Uremic hypogonadism syndrome].
    Kukhtevich AV; Ermolenko VM; Dedov II; Bunatian AF; Mel'nichenko GA
    Sov Med; 1985; (6):24-7. PubMed ID: 4059964
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sexual dysfunction in the male patients on hemodialysis].
    Kinugasa E; Tayama H; Sato Y
    Nihon Rinsho; 1997 Nov; 55(11):2996-3001. PubMed ID: 9396302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy, tolerability and safety of Parlodel LAR versus Parlodel in hyperprolactinemia.
    Bolanowski M; Milewicz A; Bohdanowicz-Pawlak A; Bednarek-Tupikowska G; Jedrzejak JA; Lancranjan I
    Endokrynol Pol; 1993; 44(4):467-76. PubMed ID: 8055815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of lysenyl-forte and methergoline in the therapy of hyperprolactinemic hypogonadism].
    Mel'nichenko GA; Dedov II; Gitel' EP; Ilovaĭskaia IA
    Probl Endokrinol (Mosk); 1991; 37(2):20-2. PubMed ID: 1857694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction.
    Mulhall JP; Valenzuela R; Aviv N; Parker M
    Urology; 2004 Feb; 63(2):348-52; discussion 352-3. PubMed ID: 14972487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nephropathy-related disorders of physical and sexual development in girls: experience with successful stimulation by zinc, parlodel and norcolut].
    Kukhtevich AV; Ermolenko VM; Kuznetsova AI; Gitel' EP; Bunatian AF; Smirnova GA; Adnoral SA
    Ter Arkh; 1993; 65(6):54-8. PubMed ID: 8378851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Parlodel treatment in the diagnosis of hyperprolactinemia].
    Pamfamirov IuK; Golubev VA; Zaets VV; Semeniuta AN
    Akush Ginekol (Mosk); 1986 Nov; (11):67-9. PubMed ID: 2949663
    [No Abstract]   [Full Text] [Related]  

  • 30. Prolactin levels in infertility and bromocriptine therapy in hyperprolactinaemia.
    Prathibha D; Govardhani M; Krishna PT
    J Indian Med Assoc; 1994 Dec; 92(12):397-9. PubMed ID: 7876578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Zinc supplements in uremic hypogonadism: absence of beneficial effects].
    del Río Vázquez A; Rico Lenza H; Romero Burgos R; Arcocha Gilo V; Novoa García D; Barrio Gómez E
    Rev Clin Esp; 1986 May; 178(8):373-6. PubMed ID: 3738015
    [No Abstract]   [Full Text] [Related]  

  • 32. Reversal of hypogonadotropic hypogonadism with tamoxifen in a patient with hyperprolactinemia resistant to dopamine agonists.
    López JM; Oestreicher E
    Fertil Steril; 2005 Sep; 84(3):756. PubMed ID: 16169415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The endocrine status of men with lupus nephritis].
    Kukhtevich AV; Ianushkevich TN; Adnoral SA; Gitel' EP
    Ter Arkh; 1994; 66(10):33-5. PubMed ID: 7863443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current possibilities of correction of hormonal imbalance in uremia].
    Ermolenko VM; Nikiforova NV; Kukhtevich AV; Lifshits NL; Strunin SE
    Ter Arkh; 1987; 59(12):104-7. PubMed ID: 3447281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new oral slow release form of bromocriptine, Parlodel SRO, in the chronic treatment of 26 hyperprolactinemic patients.
    Gianola D; Pedroncelli A; Montini M; Tengattini F; Pagani MD; Cortesi L; Cappi MP; Gherardi F; Lancranjan I; Pagani G
    Gynecol Endocrinol; 1991 Sep; 5(3):213-6. PubMed ID: 1776507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromocriptine in the treatment of hypogonadism and male impotence.
    March CM
    Drugs; 1979 May; 17(5):349-58. PubMed ID: 378650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of male fertility disorders].
    Rusz A
    Orv Hetil; 2005 Nov; 146(48):2459-63. PubMed ID: 16408386
    [No Abstract]   [Full Text] [Related]  

  • 38. [Parenteral, depot and repeatable forms of Parlodel LAR bromocriptine in the treatment of hyperprolactinemia syndrome. Comparison with oral Parlodel].
    Dolecek R; Lancranjanová I; Putz Z; Vavros D; Závada M
    Cas Lek Cesk; 1993 Feb; 132(3):81-5. PubMed ID: 8458069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cabergoline and hyperprolactinaemia: new preparation. Better than bromocriptine.
    Prescrire Int; 2000 Feb; 9(45):195-7. PubMed ID: 11503793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy rate following bromocriptine treatment in infertile women with galactorrhea.
    Eftekhari N; Mohammadalizadeh S
    Gynecol Endocrinol; 2009 Feb; 25(2):122-4. PubMed ID: 19253108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.